These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Liver cirrhosis caused by genetic defects]. Mörl M; Gabriel L Med Klin; 1977 Mar; 72(12):483-91. PubMed ID: 840122 [No Abstract] [Full Text] [Related]
45. [Effects and adverse effects of D-penicillamine]. Perings E; Junge U Med Klin; 1975 Aug; 70(31):1265-74. PubMed ID: 1107780 [No Abstract] [Full Text] [Related]
47. [Myasthenia syndrome in D-penicillamine therapy in primary biliary cirrhosis]. Weinzierl M; Kruis W; Eisenburg J Internist (Berl); 1981 Feb; 22(2):93-5. PubMed ID: 7012074 [No Abstract] [Full Text] [Related]
48. [D-penicillamine]. Sternlieb I Med Chir Dig; 1973; 2(1):1-2. PubMed ID: 4729529 [No Abstract] [Full Text] [Related]
49. [Presymptomatic and hepatic forms of Wilson's disease in childhood. Long-term therapy with D-penicillamine]. Kittoe K; Colombo JP Praxis; 1968 Dec; 57(49):1723-9. PubMed ID: 5756864 [No Abstract] [Full Text] [Related]
50. Patient with late-onset Wilson's disease: deterioration with penicillamine. Sohtaoglu M; Ergin H; Ozekmekçi S; Gökdemir S; Sonsuz A; Arici C Mov Disord; 2007 Jan; 22(2):290-1. PubMed ID: 17083099 [No Abstract] [Full Text] [Related]
51. [Experiences with long-term therapy of Wilson's disease]. Schindler H Wien Z Inn Med; 1967; 48(12):465-9. PubMed ID: 5620587 [No Abstract] [Full Text] [Related]
52. [The detection of antibodies against D-penicillamine. 3. Detection of antibodies against D-penicillamine in the serum of patients with Wilson's disease treated with D-penicillamine--preliminary results]. Trautmann B; Storch W Pharmazie; 1986 Feb; 41(2):126-7. PubMed ID: 3523546 [TBL] [Abstract][Full Text] [Related]
53. [Possible accidents due to penicillamine during treatment of Wilson's disease]. Boudin G; Pépin B Bull Acad Natl Med; 1972 May; 156(12):375-9. PubMed ID: 4572368 [No Abstract] [Full Text] [Related]
54. [Long-term therapy of liver diseases]. Markoff N Wien Med Wochenschr; 1972 Feb; 122(7):95-9. PubMed ID: 4621921 [No Abstract] [Full Text] [Related]
55. Mechanisms of pennicillamine and zinc in the treatment of Wilson's disease. Farinati F; Cardin R; Mestriner C; Sturniolo GC; Naccarato R Am J Gastroenterol; 1995 Dec; 90(12):2264-5. PubMed ID: 8540540 [No Abstract] [Full Text] [Related]
56. [Nature of course and rehabilitation in the clinical stage of Wilson's disease]. Lössner J; Eichner B; Bachmann H; Biesold D; Günther K Psychiatr Neurol Med Psychol (Leipz); 1974 Nov; 26(11):661-75. PubMed ID: 4449905 [No Abstract] [Full Text] [Related]
57. [Immune deficiency during D-penicillamine treatment ]. Michel FB; Bousquet J; Robinet-Levy M; Mary P Nouv Presse Med; 1977 Nov; 6(38):3546-7. PubMed ID: 600728 [No Abstract] [Full Text] [Related]